Zest Pharma Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Zest Pharma Pharmaceutical Export Portfolio Dataset — 3 Products, $715.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Zest Pharma — Pharmaceutical Exporter Profile (2026) | 3 Products, $715.5K Trade | TransData Nexus

Zest Pharma

Indian Pharmaceutical Exporter · Advanced Antibiotics Specialist · $715.5K Total Trade · DGFT Verified

Zest Pharma is an Indian pharmaceutical exporter with a total trade value of $715.5K across 3 products in 2 therapeutic categories. Based on 43 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Tinidazole ($335.9K), Secnidazole ($192.9K), Protein ($186.8K).

Zest Pharma — Export Portfolio & Destination Treemap

Zest Pharma pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Zest Pharma? — Company Overview & Market Position

Zest Pharma, established in 1994, is a technology-driven healthcare company headquartered in Indore, Madhya Pradesh, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, with a strong emphasis on quality and affordability. Over the years, Zest Pharma has expanded its presence to over 30 countries, particularly in Asia and Africa, earning a reputation for its commitment to quality.

The company's ownership structure is a partnership, with Mr. Sudhir Vora serving as the Managing Director. Zest Pharma operates with a dedicated team of 11 to 25 employees, reflecting its focus on maintaining a lean and efficient organizational structure. The registered office is located at 201, Navneet Darshan, 3rd Floor, 16/2 Old Palasia, Indore, Madhya Pradesh 452001, India.

What Does Zest Pharma Export? — Product Portfolio Analysis

Top Products by Export Value

1Tinidazole$335.9K 2Secnidazole

Product Portfolio — Top 3 by Export Value

Zest Pharma exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Tinidazole	Advanced Antibiotics	$335.9K	14	1.8%	10
2	Secnidazole	Advanced Antibiotics	$192.9K	14	0.6%	11
3	Protein	Nutritional Supplements	$186.8K	15	1.3%	8

Zest Pharma exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $715.5K. The top category is Advanced Antibiotics (73.9% of portfolio), followed by Nutritional Supplements (26.1%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Zest Pharma — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Zest Pharma operates a state-of-the-art manufacturing facility in Indore, Madhya Pradesh, India. This facility is WHO-GMP certified, ensuring adherence to international quality standards. The plant is equipped with modern machinery and high technical configuration, enabling the production of a diverse range of pharmaceutical formulations. The manufacturing unit's capacity and specialization are tailored to meet both domestic and international market demands, reflecting the company's commitment to quality and efficiency.

3Key Leadership

Mr. Sudhir Vora serves as the Managing Director of Zest Pharma. Under his leadership, the company has achieved significant growth and recognition in the pharmaceutical industry. His vision and commitment to quality have been instrumental in establishing Zest Pharma as a trusted name in the global market.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Zest Pharma Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Zest Pharma has made significant strides in regulated markets, particularly in the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility holds WHO-GMP certification, which is recognized by regulatory authorities in these regions. This certification facilitates the acceptance of Zest Pharma's products in these markets, ensuring compliance with stringent quality standards. While specific regulatory filings and approvals in each country are not detailed, the WHO-GMP certification serves as a testament to the company's adherence to international manufacturing practices.

2Emerging Markets

Zest Pharma has a notable presence in emerging markets, particularly in Africa, Latin America, and Southeast Asia. The company's WHO-GMP certification and commitment to quality have enabled it to establish a foothold in these regions. By offering affordable and high-quality pharmaceutical products, Zest Pharma addresses the healthcare needs of these developing markets, contributing to improved health standards.

3Geographic Strategy

Zest Pharma's geographic strategy demonstrates a balanced approach between domestic and international markets. With a significant presence in over 30 countries, the company has diversified its market reach, reducing dependence on any single region. This diversification strategy mitigates concentration risk and positions Zest Pharma for sustained growth in the global pharmaceutical industry.

Zest Pharma — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Zest Pharma's manufacturing facility is FDA-approved and WHO-GMP certified, indicating compliance with international manufacturing standards. While specific details regarding FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly disclosed, the FDA approval and WHO-GMP certification underscore the company's commitment to quality and regulatory compliance.

2WHO & EU GMP

Zest Pharma's manufacturing facility holds WHO-GMP certification, ensuring adherence to international quality standards. This certification is recognized by regulatory authorities in the European Union, facilitating market access. The company's commitment to quality is further demonstrated by its ISO 9001:2008 accreditation, reflecting a robust quality management system.

3CDSCO & Indian Regulatory

Zest Pharma operates in compliance with the Central Drugs Standard Control Organisation (CDSCO) regulations in India. The company's manufacturing facility is WHO-GMP certified, aligning with CDSCO's standards for pharmaceutical manufacturing. While specific details regarding CDSCO manufacturing licenses, state drug controller approvals, and export NOCs are not publicly disclosed, the WHO-GMP certification and ISO 9001:2008 accreditation reflect adherence to national and international regulatory requirements.

Zest Pharma — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Zest Pharma operates in a competitive landscape with several key players in the pharmaceutical industry. While specific market share comparisons are not publicly available, Zest Pharma's focus on quality and affordability positions it favorably in the market. The company's WHO-GMP certification and ISO 9001:2008 accreditation further enhance its competitive edge, ensuring compliance with international manufacturing standards.

2Key Differentiators

Zest Pharma's key differentiators include its state-of-the-art manufacturing facility, which is FDA-approved and WHO-GMP certified, and its commitment to quality and affordability. The company's focus on therapeutic areas such as gynecology, anti-microbials, pediatrics, and general medicine allows it to address a wide range of healthcare needs. Additionally, Zest Pharma's ISO 9001:2008 accreditation reflects a robust quality management system, further distinguishing it in the market.

3Strategic Position

Zest Pharma's current strategic direction focuses on expanding its presence in both domestic and international markets by offering a diverse range of pharmaceutical formulations. The company's commitment to quality, as evidenced by its WHO-GMP certification and ISO 9001:2008 accreditation, positions it well for future growth. Zest Pharma's focus on therapeutic areas such as gynecology, anti-microbials, pediatrics, and general medicine aligns with global healthcare needs, supporting its strategic objectives.

Buyer Due Diligence Brief — Evaluating Zest Pharma as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Zest Pharma has a strong track record in the pharmaceutical industry, with a focus on quality and affordability. The company's manufacturing facility is FDA-approved and WHO-GMP certified, indicating adherence to international manufacturing standards. Zest Pharma's product portfolio includes a diverse range of pharmaceutical formulations, addressing various therapeutic areas. The company's commitment to quality is further demonstrated by its ISO 9001:2008 accreditation, reflecting a robust quality management system.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm the manufacturing facility's FDA approval status to ensure compliance with U.S. regulatory standards.

WHO-GMP Certification: Verify the WHO-GMP certification to ensure adherence to international manufacturing practices.

Frequently Asked Questions — Zest Pharma

How many pharmaceutical products does Zest Pharma export from India?

Zest Pharma exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Tinidazole ($335.9K), Secnidazole ($192.9K), Protein ($186.8K). Total export value is $715.5K.

What is Zest Pharma's total pharmaceutical export value?

Zest Pharma's total pharmaceutical export value is $715.5K, based on 43 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Zest Pharma cover?

Zest Pharma exports across 2 therapeutic categories. The largest are Advanced Antibiotics (73.9%, 2 products), Nutritional Supplements (26.1%, 1 products).

Get Full Zest Pharma Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.